Multiple Sclerosis Clinical Trials in San Antonio

Showing 421-440 of 513 trials

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

NCT00786747

The study investigators have developed an interactive multimedia computer program that provides personally tailored education about colorectal cancer screening in the user's preferred language (English or Spanish). In this study, the investigators will examine whether use of the computer program increases the number of Hispanic patients who receive colorectal cancer screening and lessens or eliminates the glaring disparity in screening between Hispanics and non-Hispanic whites.

Colorectal Neoplasms

University of California, Davis1,164 participantsStarted Feb 2010

Sacramento, California, United States • Aurora, Colorado, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

NCT00036270

To compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early breast cancer. This Pfizer sponsored trial is part of an international collaboration of investigators conducting 7 similar yet independent studies in 9 countries. This study is designed to be part of the larger TEAM trial where the data from these 7 studies will be combined. A pre-specified analysis of the pooled data will be conducted.

Breast Neoplasms

Pfizer9,779 participantsStarted Aug 2001

Bessemer, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +176 more locations

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

Multiple Sclerosis Trials in Other Cities

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Safety Study for the Treatment of Abdominal Aortic Aneurysms

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Other Conditions in San Antonio